CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (123,315)	$ 134,426
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	1,028	1,425
Foreign currency transaction gain	(30,093)	(20,857)
Changes in operating assets and liabilities:
Research supplies	607	0
Grant funds receivable	15,901	(13,560)
Development Agreement receivables	0	5,813
Prepaid expenses and other current assets	9,632	19,970
Accounts payable and accrued liabilities	(43,581)	(88,684)
Deferred revenue	0	(80,114)
Other liabilities	(45)	0
NET CASH USED IN OPERATING ACTIVITIES	(169,866)	(41,581)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock	40,000	0
Proceeds from issuance of preferred stock	179,600	0
Deposit for preferred stock	0	60,090
Proceeds from related party loan	0	61,434
Repayment of related party loan	0	(58,172)
NET CASH PROVIDED BY FINANCING ACTIVITIES	219,600	63,352
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(6,655)	(13,006)
NET INCREASE IN CASH AND CASH EQUIVALENTS	43,079	8,765
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	89,132	113,915
CASH AND CASH EQUIVALENTS - END OF PERIOD	$ 132,211	$ 122,680